Since the inclusion criterion for our T2DM subjects was an increased fasting plasma glucose level (>7 mmol/l), which is a surrogate measure for insulin sensitivity, this indicates that the correlation of insulin sensitivity with glycine may extend to subjects with extreme overweight and T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.